PCRX · Pharmacorp Rx Inc.
0.49
CADUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
CA$96.11M
PE
N/A
EV/EBITDA
N/A
DIV Yield
N/A
Payout Ratio
N/A
MQV Rating
5Very Weak
As at 24/08/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Consensus Cheap
- HALO All
- HALO Growth
- Recent Earnings upgrade
Key Fundamentals
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Performance
52 weeks range
N/A
Trade Value (12mth)
N/A
1 week
%
1 month
%
YTD
%
1 year
%
All time high
N/A
Additional Data
Shares Outstanding (Fully Diluted)
N/A
HALO Sector
Other Finance
Next Company Report Date
N/A
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
N/A
Short Sell (% of issue)
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Strong
Earnings
Strong
Growth
Earnings
Very Strong
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Neutral
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Alan Arthur Simpson | Individual |
| Kimberly Carroll | Individual |
| Grady Brown | Individual |
| Glenn Edward Fradette | Individual |
| Ken Brownell | Individual |
